Dr. Reddy's Labs Files 6-K Report
Ticker: RDY · Form: 6-K · Filed: Dec 23, 2025 · CIK: 1135951
Sentiment: neutral
Topics: reporting, sec-filing, foreign-private-issuer
TL;DR
DRL filed a 6-K, confirming 20-F annual reports and its status as a foreign private issuer.
AI Summary
Dr. Reddy's Laboratories Ltd. filed a Form 6-K on December 23, 2025, reporting as a foreign private issuer. The company, based in Hyderabad, India, is a pharmaceutical preparations manufacturer and will file its annual reports under Form 20-F.
Why It Matters
This filing indicates Dr. Reddy's Laboratories is adhering to its reporting obligations as a foreign private issuer with the SEC, providing transparency to investors.
Risk Assessment
Risk Level: low — This is a routine administrative filing confirming reporting status and not disclosing new material financial or operational information.
Key Players & Entities
- Dr. Reddy's Laboratories Ltd. (company) — Registrant
- 20251223 (date) — Filing Date
- Hyderabad, India (location) — Company Headquarters
- Form 6-K (document) — Filing Type
- Form 20-F (document) — Annual Report Form
FAQ
What is the primary purpose of this Form 6-K filing?
The Form 6-K is a Report of Foreign Private Issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, indicating Dr. Reddy's Laboratories Ltd. is providing information to the SEC.
When was this Form 6-K filed?
The filing was made on December 23, 2025.
Where is Dr. Reddy's Laboratories Ltd. headquartered?
The company is headquartered at 8-2-337, Road No. 3, Banjara Hills, Hyderabad, Telangana 500 034, India.
Under which form will Dr. Reddy's Laboratories Ltd. file its annual reports?
Dr. Reddy's Laboratories Ltd. will file its annual reports under cover of Form 20-F.
What is the SIC code for Dr. Reddy's Laboratories Ltd.?
The Standard Industrial Classification (SIC) code for Dr. Reddy's Laboratories Ltd. is 2834, which corresponds to Pharmaceutical Preparations.
Filing Stats: 399 words · 2 min read · ~1 pages · Grade level 16.5 · Accepted 2025-12-23 07:33:05
Filing Documents
- rdy0834_6k.htm (6-K) — 38KB
- rdy0834_ex99-1.htm (EX-99.1) — 17KB
- rdy0834_ex99-1img01.jpg (GRAPHIC) — 10KB
- rdy0834_ex99-1img02.jpg (GRAPHIC) — 4KB
- 0001575872-25-000769.txt ( ) — 75KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized. DR. REDDY'S LABORATORIES LIMITED (Registrant) Date: December 23, 2025 By: /s/ K Randhir Singh Name: K Randhir Singh Title: Company Secretary 3